The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chorionic Gonadotrophin Market Research Report 2024
Synopsis
Human chorionic gonadotropin (HCG), a polypeptide hormone produced by the human placenta. Endogenously produced HCG interacts with the LHCG receptor of the ovary and promotes the maintenance of the corpus luteum during the beginning of pregnancy. This allows the corpus luteum to continuously secrete the hormone progesterone during the first trimester, which is required for maintenance of the uterus and prevents menstruation. In males, HCG also stimulates the production of gonadal steroid hormones by stimulating the interstitial cells (Leydig cells) of the testis to produce androgens.
The global Chorionic Gonadotrophin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chorionic Gonadotrophin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chorionic Gonadotrophin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chorionic Gonadotrophin include Merck Serono, Bristol Myers Squibb, Ferring, Fresenius Kabi, Sun Pharmaceutical, Besins Healthcare Benelux, Jean-Marie, Organon and Hubei Dongxin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chorionic Gonadotrophin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chorionic Gonadotrophin.
Report Scope
The Chorionic Gonadotrophin market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chorionic Gonadotrophin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chorionic Gonadotrophin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Serono
Bristol Myers Squibb
Ferring
Fresenius Kabi
Sun Pharmaceutical
Besins Healthcare Benelux
Jean-Marie
Organon
Hubei Dongxin Pharmaceutical
Changchun Jinsai Pharmaceutical
Ningbo Renjian Pharmaceutical Group
Yantai Dongcheng North Pharmaceutical
Maanshan Fengyuan Pharmaceutical
Sinopharm
Livzon Pharmaceutical Group
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Segment by Type
500U
1000U
2000U
3000U
5000U
Segment by Application
Undescended Testicles In Adolescence
Male Infertility
Female Anovulatory Infertility
In Vitro Fertilization
Abortion
Functional Uterine Hemorrhage
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chorionic Gonadotrophin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chorionic Gonadotrophin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Human chorionic gonadotropin (HCG), a polypeptide hormone produced by the human placenta. Endogenously produced HCG interacts with the LHCG receptor of the ovary and promotes the maintenance of the corpus luteum during the beginning of pregnancy. This allows the corpus luteum to continuously secrete the hormone progesterone during the first trimester, which is required for maintenance of the uterus and prevents menstruation. In males, HCG also stimulates the production of gonadal steroid hormones by stimulating the interstitial cells (Leydig cells) of the testis to produce androgens.
The global Chorionic Gonadotrophin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chorionic Gonadotrophin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chorionic Gonadotrophin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chorionic Gonadotrophin include Merck Serono, Bristol Myers Squibb, Ferring, Fresenius Kabi, Sun Pharmaceutical, Besins Healthcare Benelux, Jean-Marie, Organon and Hubei Dongxin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chorionic Gonadotrophin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chorionic Gonadotrophin.
Report Scope
The Chorionic Gonadotrophin market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chorionic Gonadotrophin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chorionic Gonadotrophin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Serono
Bristol Myers Squibb
Ferring
Fresenius Kabi
Sun Pharmaceutical
Besins Healthcare Benelux
Jean-Marie
Organon
Hubei Dongxin Pharmaceutical
Changchun Jinsai Pharmaceutical
Ningbo Renjian Pharmaceutical Group
Yantai Dongcheng North Pharmaceutical
Maanshan Fengyuan Pharmaceutical
Sinopharm
Livzon Pharmaceutical Group
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Segment by Type
500U
1000U
2000U
3000U
5000U
Segment by Application
Undescended Testicles In Adolescence
Male Infertility
Female Anovulatory Infertility
In Vitro Fertilization
Abortion
Functional Uterine Hemorrhage
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chorionic Gonadotrophin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chorionic Gonadotrophin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Chorionic Gonadotrophin Market Overview
1.1 Product Overview and Scope of Chorionic Gonadotrophin
1.2 Chorionic Gonadotrophin Segment by Type
1.2.1 Global Chorionic Gonadotrophin Market Value Comparison by Type (2024-2030)
1.2.2 500U
1.2.3 1000U
1.2.4 2000U
1.2.5 3000U
1.2.6 5000U
1.3 Chorionic Gonadotrophin Segment by Application
1.3.1 Global Chorionic Gonadotrophin Market Value by Application: (2024-2030)
1.3.2 Undescended Testicles In Adolescence
1.3.3 Male Infertility
1.3.4 Female Anovulatory Infertility
1.3.5 In Vitro Fertilization
1.3.6 Abortion
1.3.7 Functional Uterine Hemorrhage
1.3.8 Other
1.4 Global Chorionic Gonadotrophin Market Size Estimates and Forecasts
1.4.1 Global Chorionic Gonadotrophin Revenue 2019-2030
1.4.2 Global Chorionic Gonadotrophin Sales 2019-2030
1.4.3 Global Chorionic Gonadotrophin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chorionic Gonadotrophin Market Competition by Manufacturers
2.1 Global Chorionic Gonadotrophin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chorionic Gonadotrophin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chorionic Gonadotrophin Average Price by Manufacturers (2019-2024)
2.4 Global Chorionic Gonadotrophin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chorionic Gonadotrophin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chorionic Gonadotrophin, Product Type & Application
2.7 Chorionic Gonadotrophin Market Competitive Situation and Trends
2.7.1 Chorionic Gonadotrophin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chorionic Gonadotrophin Players Market Share by Revenue
2.7.3 Global Chorionic Gonadotrophin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chorionic Gonadotrophin Retrospective Market Scenario by Region
3.1 Global Chorionic Gonadotrophin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chorionic Gonadotrophin Global Chorionic Gonadotrophin Sales by Region: 2019-2030
3.2.1 Global Chorionic Gonadotrophin Sales by Region: 2019-2024
3.2.2 Global Chorionic Gonadotrophin Sales by Region: 2025-2030
3.3 Global Chorionic Gonadotrophin Global Chorionic Gonadotrophin Revenue by Region: 2019-2030
3.3.1 Global Chorionic Gonadotrophin Revenue by Region: 2019-2024
3.3.2 Global Chorionic Gonadotrophin Revenue by Region: 2025-2030
3.4 North America Chorionic Gonadotrophin Market Facts & Figures by Country
3.4.1 North America Chorionic Gonadotrophin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chorionic Gonadotrophin Sales by Country (2019-2030)
3.4.3 North America Chorionic Gonadotrophin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Chorionic Gonadotrophin Market Facts & Figures by Country
3.5.1 Europe Chorionic Gonadotrophin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chorionic Gonadotrophin Sales by Country (2019-2030)
3.5.3 Europe Chorionic Gonadotrophin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chorionic Gonadotrophin Market Facts & Figures by Country
3.6.1 Asia Pacific Chorionic Gonadotrophin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chorionic Gonadotrophin Sales by Country (2019-2030)
3.6.3 Asia Pacific Chorionic Gonadotrophin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Chorionic Gonadotrophin Market Facts & Figures by Country
3.7.1 Latin America Chorionic Gonadotrophin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chorionic Gonadotrophin Sales by Country (2019-2030)
3.7.3 Latin America Chorionic Gonadotrophin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chorionic Gonadotrophin Market Facts & Figures by Country
3.8.1 Middle East and Africa Chorionic Gonadotrophin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chorionic Gonadotrophin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chorionic Gonadotrophin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chorionic Gonadotrophin Sales by Type (2019-2030)
4.1.1 Global Chorionic Gonadotrophin Sales by Type (2019-2024)
4.1.2 Global Chorionic Gonadotrophin Sales by Type (2025-2030)
4.1.3 Global Chorionic Gonadotrophin Sales Market Share by Type (2019-2030)
4.2 Global Chorionic Gonadotrophin Revenue by Type (2019-2030)
4.2.1 Global Chorionic Gonadotrophin Revenue by Type (2019-2024)
4.2.2 Global Chorionic Gonadotrophin Revenue by Type (2025-2030)
4.2.3 Global Chorionic Gonadotrophin Revenue Market Share by Type (2019-2030)
4.3 Global Chorionic Gonadotrophin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chorionic Gonadotrophin Sales by Application (2019-2030)
5.1.1 Global Chorionic Gonadotrophin Sales by Application (2019-2024)
5.1.2 Global Chorionic Gonadotrophin Sales by Application (2025-2030)
5.1.3 Global Chorionic Gonadotrophin Sales Market Share by Application (2019-2030)
5.2 Global Chorionic Gonadotrophin Revenue by Application (2019-2030)
5.2.1 Global Chorionic Gonadotrophin Revenue by Application (2019-2024)
5.2.2 Global Chorionic Gonadotrophin Revenue by Application (2025-2030)
5.2.3 Global Chorionic Gonadotrophin Revenue Market Share by Application (2019-2030)
5.3 Global Chorionic Gonadotrophin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck Serono
6.1.1 Merck Serono Corporation Information
6.1.2 Merck Serono Description and Business Overview
6.1.3 Merck Serono Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Serono Chorionic Gonadotrophin Product Portfolio
6.1.5 Merck Serono Recent Developments/Updates
6.2 Bristol Myers Squibb
6.2.1 Bristol Myers Squibb Corporation Information
6.2.2 Bristol Myers Squibb Description and Business Overview
6.2.3 Bristol Myers Squibb Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bristol Myers Squibb Chorionic Gonadotrophin Product Portfolio
6.2.5 Bristol Myers Squibb Recent Developments/Updates
6.3 Ferring
6.3.1 Ferring Corporation Information
6.3.2 Ferring Description and Business Overview
6.3.3 Ferring Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ferring Chorionic Gonadotrophin Product Portfolio
6.3.5 Ferring Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius Kabi Chorionic Gonadotrophin Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Sun Pharmaceutical
6.5.1 Sun Pharmaceutical Corporation Information
6.5.2 Sun Pharmaceutical Description and Business Overview
6.5.3 Sun Pharmaceutical Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sun Pharmaceutical Chorionic Gonadotrophin Product Portfolio
6.5.5 Sun Pharmaceutical Recent Developments/Updates
6.6 Besins Healthcare Benelux
6.6.1 Besins Healthcare Benelux Corporation Information
6.6.2 Besins Healthcare Benelux Description and Business Overview
6.6.3 Besins Healthcare Benelux Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Besins Healthcare Benelux Chorionic Gonadotrophin Product Portfolio
6.6.5 Besins Healthcare Benelux Recent Developments/Updates
6.7 Jean-Marie
6.6.1 Jean-Marie Corporation Information
6.6.2 Jean-Marie Description and Business Overview
6.6.3 Jean-Marie Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jean-Marie Chorionic Gonadotrophin Product Portfolio
6.7.5 Jean-Marie Recent Developments/Updates
6.8 Organon
6.8.1 Organon Corporation Information
6.8.2 Organon Description and Business Overview
6.8.3 Organon Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Organon Chorionic Gonadotrophin Product Portfolio
6.8.5 Organon Recent Developments/Updates
6.9 Hubei Dongxin Pharmaceutical
6.9.1 Hubei Dongxin Pharmaceutical Corporation Information
6.9.2 Hubei Dongxin Pharmaceutical Description and Business Overview
6.9.3 Hubei Dongxin Pharmaceutical Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hubei Dongxin Pharmaceutical Chorionic Gonadotrophin Product Portfolio
6.9.5 Hubei Dongxin Pharmaceutical Recent Developments/Updates
6.10 Changchun Jinsai Pharmaceutical
6.10.1 Changchun Jinsai Pharmaceutical Corporation Information
6.10.2 Changchun Jinsai Pharmaceutical Description and Business Overview
6.10.3 Changchun Jinsai Pharmaceutical Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Changchun Jinsai Pharmaceutical Chorionic Gonadotrophin Product Portfolio
6.10.5 Changchun Jinsai Pharmaceutical Recent Developments/Updates
6.11 Ningbo Renjian Pharmaceutical Group
6.11.1 Ningbo Renjian Pharmaceutical Group Corporation Information
6.11.2 Ningbo Renjian Pharmaceutical Group Chorionic Gonadotrophin Description and Business Overview
6.11.3 Ningbo Renjian Pharmaceutical Group Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Ningbo Renjian Pharmaceutical Group Chorionic Gonadotrophin Product Portfolio
6.11.5 Ningbo Renjian Pharmaceutical Group Recent Developments/Updates
6.12 Yantai Dongcheng North Pharmaceutical
6.12.1 Yantai Dongcheng North Pharmaceutical Corporation Information
6.12.2 Yantai Dongcheng North Pharmaceutical Chorionic Gonadotrophin Description and Business Overview
6.12.3 Yantai Dongcheng North Pharmaceutical Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yantai Dongcheng North Pharmaceutical Chorionic Gonadotrophin Product Portfolio
6.12.5 Yantai Dongcheng North Pharmaceutical Recent Developments/Updates
6.13 Maanshan Fengyuan Pharmaceutical
6.13.1 Maanshan Fengyuan Pharmaceutical Corporation Information
6.13.2 Maanshan Fengyuan Pharmaceutical Chorionic Gonadotrophin Description and Business Overview
6.13.3 Maanshan Fengyuan Pharmaceutical Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Maanshan Fengyuan Pharmaceutical Chorionic Gonadotrophin Product Portfolio
6.13.5 Maanshan Fengyuan Pharmaceutical Recent Developments/Updates
6.14 Sinopharm
6.14.1 Sinopharm Corporation Information
6.14.2 Sinopharm Chorionic Gonadotrophin Description and Business Overview
6.14.3 Sinopharm Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sinopharm Chorionic Gonadotrophin Product Portfolio
6.14.5 Sinopharm Recent Developments/Updates
6.15 Livzon Pharmaceutical Group
6.15.1 Livzon Pharmaceutical Group Corporation Information
6.15.2 Livzon Pharmaceutical Group Chorionic Gonadotrophin Description and Business Overview
6.15.3 Livzon Pharmaceutical Group Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Livzon Pharmaceutical Group Chorionic Gonadotrophin Product Portfolio
6.15.5 Livzon Pharmaceutical Group Recent Developments/Updates
6.16 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
6.16.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporation Information
6.16.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Chorionic Gonadotrophin Description and Business Overview
6.16.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Chorionic Gonadotrophin Product Portfolio
6.16.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chorionic Gonadotrophin Industry Chain Analysis
7.2 Chorionic Gonadotrophin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chorionic Gonadotrophin Production Mode & Process
7.4 Chorionic Gonadotrophin Sales and Marketing
7.4.1 Chorionic Gonadotrophin Sales Channels
7.4.2 Chorionic Gonadotrophin Distributors
7.5 Chorionic Gonadotrophin Customers
8 Chorionic Gonadotrophin Market Dynamics
8.1 Chorionic Gonadotrophin Industry Trends
8.2 Chorionic Gonadotrophin Market Drivers
8.3 Chorionic Gonadotrophin Market Challenges
8.4 Chorionic Gonadotrophin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Chorionic Gonadotrophin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Chorionic Gonadotrophin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Chorionic Gonadotrophin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Chorionic Gonadotrophin Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Chorionic Gonadotrophin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Chorionic Gonadotrophin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Chorionic Gonadotrophin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Chorionic Gonadotrophin Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Chorionic Gonadotrophin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chorionic Gonadotrophin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chorionic Gonadotrophin, Product Type & Application
Table 12. Global Key Manufacturers of Chorionic Gonadotrophin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chorionic Gonadotrophin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chorionic Gonadotrophin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chorionic Gonadotrophin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Chorionic Gonadotrophin Sales by Region (2019-2024) & (KG)
Table 18. Global Chorionic Gonadotrophin Sales Market Share by Region (2019-2024)
Table 19. Global Chorionic Gonadotrophin Sales by Region (2025-2030) & (KG)
Table 20. Global Chorionic Gonadotrophin Sales Market Share by Region (2025-2030)
Table 21. Global Chorionic Gonadotrophin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Chorionic Gonadotrophin Revenue Market Share by Region (2019-2024)
Table 23. Global Chorionic Gonadotrophin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Chorionic Gonadotrophin Revenue Market Share by Region (2025-2030)
Table 25. North America Chorionic Gonadotrophin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Chorionic Gonadotrophin Sales by Country (2019-2024) & (KG)
Table 27. North America Chorionic Gonadotrophin Sales by Country (2025-2030) & (KG)
Table 28. North America Chorionic Gonadotrophin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Chorionic Gonadotrophin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Chorionic Gonadotrophin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Chorionic Gonadotrophin Sales by Country (2019-2024) & (KG)
Table 32. Europe Chorionic Gonadotrophin Sales by Country (2025-2030) & (KG)
Table 33. Europe Chorionic Gonadotrophin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Chorionic Gonadotrophin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Chorionic Gonadotrophin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Chorionic Gonadotrophin Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Chorionic Gonadotrophin Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Chorionic Gonadotrophin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Chorionic Gonadotrophin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chorionic Gonadotrophin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Chorionic Gonadotrophin Sales by Country (2019-2024) & (KG)
Table 42. Latin America Chorionic Gonadotrophin Sales by Country (2025-2030) & (KG)
Table 43. Latin America Chorionic Gonadotrophin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chorionic Gonadotrophin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chorionic Gonadotrophin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Chorionic Gonadotrophin Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Chorionic Gonadotrophin Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Chorionic Gonadotrophin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Chorionic Gonadotrophin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Chorionic Gonadotrophin Sales (KG) by Type (2019-2024)
Table 51. Global Chorionic Gonadotrophin Sales (KG) by Type (2025-2030)
Table 52. Global Chorionic Gonadotrophin Sales Market Share by Type (2019-2024)
Table 53. Global Chorionic Gonadotrophin Sales Market Share by Type (2025-2030)
Table 54. Global Chorionic Gonadotrophin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Chorionic Gonadotrophin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Chorionic Gonadotrophin Revenue Market Share by Type (2019-2024)
Table 57. Global Chorionic Gonadotrophin Revenue Market Share by Type (2025-2030)
Table 58. Global Chorionic Gonadotrophin Price (US$/G) by Type (2019-2024)
Table 59. Global Chorionic Gonadotrophin Price (US$/G) by Type (2025-2030)
Table 60. Global Chorionic Gonadotrophin Sales (KG) by Application (2019-2024)
Table 61. Global Chorionic Gonadotrophin Sales (KG) by Application (2025-2030)
Table 62. Global Chorionic Gonadotrophin Sales Market Share by Application (2019-2024)
Table 63. Global Chorionic Gonadotrophin Sales Market Share by Application (2025-2030)
Table 64. Global Chorionic Gonadotrophin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Chorionic Gonadotrophin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Chorionic Gonadotrophin Revenue Market Share by Application (2019-2024)
Table 67. Global Chorionic Gonadotrophin Revenue Market Share by Application (2025-2030)
Table 68. Global Chorionic Gonadotrophin Price (US$/G) by Application (2019-2024)
Table 69. Global Chorionic Gonadotrophin Price (US$/G) by Application (2025-2030)
Table 70. Merck Serono Corporation Information
Table 71. Merck Serono Description and Business Overview
Table 72. Merck Serono Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Merck Serono Chorionic Gonadotrophin Product
Table 74. Merck Serono Recent Developments/Updates
Table 75. Bristol Myers Squibb Corporation Information
Table 76. Bristol Myers Squibb Description and Business Overview
Table 77. Bristol Myers Squibb Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Bristol Myers Squibb Chorionic Gonadotrophin Product
Table 79. Bristol Myers Squibb Recent Developments/Updates
Table 80. Ferring Corporation Information
Table 81. Ferring Description and Business Overview
Table 82. Ferring Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Ferring Chorionic Gonadotrophin Product
Table 84. Ferring Recent Developments/Updates
Table 85. Fresenius Kabi Corporation Information
Table 86. Fresenius Kabi Description and Business Overview
Table 87. Fresenius Kabi Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Fresenius Kabi Chorionic Gonadotrophin Product
Table 89. Fresenius Kabi Recent Developments/Updates
Table 90. Sun Pharmaceutical Corporation Information
Table 91. Sun Pharmaceutical Description and Business Overview
Table 92. Sun Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Sun Pharmaceutical Chorionic Gonadotrophin Product
Table 94. Sun Pharmaceutical Recent Developments/Updates
Table 95. Besins Healthcare Benelux Corporation Information
Table 96. Besins Healthcare Benelux Description and Business Overview
Table 97. Besins Healthcare Benelux Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Besins Healthcare Benelux Chorionic Gonadotrophin Product
Table 99. Besins Healthcare Benelux Recent Developments/Updates
Table 100. Jean-Marie Corporation Information
Table 101. Jean-Marie Description and Business Overview
Table 102. Jean-Marie Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Jean-Marie Chorionic Gonadotrophin Product
Table 104. Jean-Marie Recent Developments/Updates
Table 105. Organon Corporation Information
Table 106. Organon Description and Business Overview
Table 107. Organon Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Organon Chorionic Gonadotrophin Product
Table 109. Organon Recent Developments/Updates
Table 110. Hubei Dongxin Pharmaceutical Corporation Information
Table 111. Hubei Dongxin Pharmaceutical Description and Business Overview
Table 112. Hubei Dongxin Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. Hubei Dongxin Pharmaceutical Chorionic Gonadotrophin Product
Table 114. Hubei Dongxin Pharmaceutical Recent Developments/Updates
Table 115. Changchun Jinsai Pharmaceutical Corporation Information
Table 116. Changchun Jinsai Pharmaceutical Description and Business Overview
Table 117. Changchun Jinsai Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 118. Changchun Jinsai Pharmaceutical Chorionic Gonadotrophin Product
Table 119. Changchun Jinsai Pharmaceutical Recent Developments/Updates
Table 120. Ningbo Renjian Pharmaceutical Group Corporation Information
Table 121. Ningbo Renjian Pharmaceutical Group Description and Business Overview
Table 122. Ningbo Renjian Pharmaceutical Group Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 123. Ningbo Renjian Pharmaceutical Group Chorionic Gonadotrophin Product
Table 124. Ningbo Renjian Pharmaceutical Group Recent Developments/Updates
Table 125. Yantai Dongcheng North Pharmaceutical Corporation Information
Table 126. Yantai Dongcheng North Pharmaceutical Description and Business Overview
Table 127. Yantai Dongcheng North Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 128. Yantai Dongcheng North Pharmaceutical Chorionic Gonadotrophin Product
Table 129. Yantai Dongcheng North Pharmaceutical Recent Developments/Updates
Table 130. Maanshan Fengyuan Pharmaceutical Corporation Information
Table 131. Maanshan Fengyuan Pharmaceutical Description and Business Overview
Table 132. Maanshan Fengyuan Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 133. Maanshan Fengyuan Pharmaceutical Chorionic Gonadotrophin Product
Table 134. Maanshan Fengyuan Pharmaceutical Recent Developments/Updates
Table 135. Sinopharm Corporation Information
Table 136. Sinopharm Description and Business Overview
Table 137. Sinopharm Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 138. Sinopharm Chorionic Gonadotrophin Product
Table 139. Sinopharm Recent Developments/Updates
Table 140. Livzon Pharmaceutical Group Corporation Information
Table 141. Livzon Pharmaceutical Group Description and Business Overview
Table 142. Livzon Pharmaceutical Group Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 143. Livzon Pharmaceutical Group Chorionic Gonadotrophin Product
Table 144. Livzon Pharmaceutical Group Recent Developments/Updates
Table 145. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporation Information
Table 146. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Description and Business Overview
Table 147. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 148. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Chorionic Gonadotrophin Product
Table 149. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Chorionic Gonadotrophin Distributors List
Table 153. Chorionic Gonadotrophin Customers List
Table 154. Chorionic Gonadotrophin Market Trends
Table 155. Chorionic Gonadotrophin Market Drivers
Table 156. Chorionic Gonadotrophin Market Challenges
Table 157. Chorionic Gonadotrophin Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chorionic Gonadotrophin
Figure 2. Global Chorionic Gonadotrophin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Chorionic Gonadotrophin Market Share by Type in 2023 & 2030
Figure 4. 500U Product Picture
Figure 5. 1000U Product Picture
Figure 6. 2000U Product Picture
Figure 7. 3000U Product Picture
Figure 8. 5000U Product Picture
Figure 9. Global Chorionic Gonadotrophin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Chorionic Gonadotrophin Market Share by Application in 2023 & 2030
Figure 11. Undescended Testicles In Adolescence
Figure 12. Male Infertility
Figure 13. Female Anovulatory Infertility
Figure 14. In Vitro Fertilization
Figure 15. Abortion
Figure 16. Functional Uterine Hemorrhage
Figure 17. Other
Figure 18. Global Chorionic Gonadotrophin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Chorionic Gonadotrophin Market Size (2019-2030) & (US$ Million)
Figure 20. Global Chorionic Gonadotrophin Sales (2019-2030) & (KG)
Figure 21. Global Chorionic Gonadotrophin Average Price (US$/G) & (2019-2030)
Figure 22. Chorionic Gonadotrophin Report Years Considered
Figure 23. Chorionic Gonadotrophin Sales Share by Manufacturers in 2023
Figure 24. Global Chorionic Gonadotrophin Revenue Share by Manufacturers in 2023
Figure 25. The Global 5 and 10 Largest Chorionic Gonadotrophin Players: Market Share by Revenue in 2023
Figure 26. Chorionic Gonadotrophin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 27. Global Chorionic Gonadotrophin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 28. North America Chorionic Gonadotrophin Sales Market Share by Country (2019-2030)
Figure 29. North America Chorionic Gonadotrophin Revenue Market Share by Country (2019-2030)
Figure 30. U.S. Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Canada Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Europe Chorionic Gonadotrophin Sales Market Share by Country (2019-2030)
Figure 33. Europe Chorionic Gonadotrophin Revenue Market Share by Country (2019-2030)
Figure 34. Germany Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. France Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. U.K. Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Italy Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Russia Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Asia Pacific Chorionic Gonadotrophin Sales Market Share by Region (2019-2030)
Figure 40. Asia Pacific Chorionic Gonadotrophin Revenue Market Share by Region (2019-2030)
Figure 41. China Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Japan Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. South Korea Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. India Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Australia Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Taiwan Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Indonesia Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Thailand Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Malaysia Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Philippines Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Latin America Chorionic Gonadotrophin Sales Market Share by Country (2019-2030)
Figure 52. Latin America Chorionic Gonadotrophin Revenue Market Share by Country (2019-2030)
Figure 53. Mexico Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Brazil Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Argentina Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Middle East & Africa Chorionic Gonadotrophin Sales Market Share by Country (2019-2030)
Figure 57. Middle East & Africa Chorionic Gonadotrophin Revenue Market Share by Country (2019-2030)
Figure 58. Turkey Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. UAE Chorionic Gonadotrophin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 61. Global Sales Market Share of Chorionic Gonadotrophin by Type (2019-2030)
Figure 62. Global Revenue Market Share of Chorionic Gonadotrophin by Type (2019-2030)
Figure 63. Global Chorionic Gonadotrophin Price (US$/G) by Type (2019-2030)
Figure 64. Global Sales Market Share of Chorionic Gonadotrophin by Application (2019-2030)
Figure 65. Global Revenue Market Share of Chorionic Gonadotrophin by Application (2019-2030)
Figure 66. Global Chorionic Gonadotrophin Price (US$/G) by Application (2019-2030)
Figure 67. Chorionic Gonadotrophin Value Chain
Figure 68. Chorionic Gonadotrophin Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
